Prostatype Genomics AB (publ) (PROGEN.ST)

SEK 10.3

(-8.04%)

Annual Balance Sheets

(In SEK)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 49.22 Million 30.95 Million 40.2 Million 33.66 Million 17.57 Million 19.71 Million
Total Current Assets 25.91 Million 14.16 Million 21.58 Million 17.45 Million 4.47 Million 9.7 Million
Cash And Short Term Investments 24.17 Million 11.48 Million 20.32 Million 15.86 Million 2.69 Million 8.2 Million
Cash and Cash Equivalents 2.68 Million 4.81 Million 9.82 Million 15.86 Million 2.69 Million 8.2 Million
Short Term Investments 21.49 Million 6.67 Million 10.5 Million - - -
Net Receivables 1.53 Million 2.49 Million 1.07 Million 1.19 Million 1.12 Million 1.11 Million
Inventory 203 Thousand 43.8 Thousand 107.52 Thousand 394.94 Thousand 664 Thousand 376 Thousand
Other Current Assets 1000.00 138.48 Thousand 74.5 Thousand 863.1 Thousand 1.11 Million 100.00
Total Non-Current Assets 23.31 Million 16.78 Million 18.61 Million 16.2 Million 13.09 Million 10.01 Million
Net PPE 60 Thousand 3599.00 14.08 Thousand 28.22 Thousand 39.55 Thousand 92.34 Thousand
Good Will And Intangible Assets 23.18 Million 16.7 Million 18.6 Million 111.52 Thousand 13.05 Million 9.89 Million
Good Will - - - - - -
Intangible Assets 23.18 Million 16.7 Million 18.6 Million 111.52 Thousand 13.05 Million 9.89 Million
Long-Term Investments 72 Thousand -6.6 Million - - - -
Tax Assets -23.25 Million - - - - -
Other Non Current Assets 23.25 Million 6.67 Million - 16.06 Million - 20.1 Thousand
Other Assets - - - 1.00 - -
Total Liabilities 24.54 Million 4.79 Million 4.29 Million 5.37 Million 9.02 Million 13.48 Million
Total Current Liabilities 24.48 Million 4.33 Million 3.43 Million 4.3 Million 2.57 Million 3.93 Million
Account Payables 9.44 Million 2.18 Million 1.17 Million 1.77 Million 652.54 Thousand 1.17 Million
Tax Payables 104 Thousand 240.28 Thousand 176.87 Thousand 55.37 Thousand 61.05 Thousand 91.75 Thousand
Short Term Debt 11.6 Million 400 Thousand 400 Thousand 400 Thousand 400 Thousand 26.04 Thousand
Deferred Revenue -21.04 Million 1.28 Million 1.64 Million 55.37 Thousand 1.4 Million 2.47 Million
Other Current Liabilities 24.48 Million 461.36 Thousand 212.17 Thousand 2.07 Million 117.67 Thousand 264.7 Thousand
Total Non Current Liabilities 66.99 Thousand 466.66 Thousand 866.66 Thousand 1.06 Million 6.45 Million 9.55 Million
Long-Term Debt 67 Thousand 466.66 Thousand 866.66 Thousand 1.06 Million 6.45 Million 9.55 Million
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -1.00 2.00 -1.00 -1.00 - -
Other Liabilities 1.00 - - 1.00 - -
Total Equity 24.67 Million 26.15 Million 35.9 Million 28.29 Million 8.54 Million 6.22 Million
Stock Holders Equity 24.67 Million 26.15 Million 35.9 Million 28.29 Million 8.54 Million 6.22 Million
Common Stock 7.16 Million 1.37 Million 905.32 Thousand 791.21 Thousand 1.02 Million 1.02 Million
Retained Earnings - -141.24 Million -114.01 Million -95.88 Million -76.55 Million -64.77 Million
Accumulated other comprehensive income 17.5 Million 16.7 Million 18.56 Million 16.06 Million 13.47 Million -
Common Stock Equity 24.67 Million 26.15 Million 35.9 Million 28.29 Million 8.54 Million 6.22 Million
Capital Lease Obligation - - - - - -
Total Investments 21.56 Million 68.13 Thousand 10.5 Million - - -
Total Debt 67 Thousand 866.66 Thousand 1.26 Million 1.46 Million 6.85 Million 9.57 Million
Net Debt -2.61 Million -3.94 Million -8.56 Million -14.39 Million 4.16 Million 1.36 Million

Balance Sheet Charts